Europe
endpoint Clinical, the leading global interactive response technology company, and Cmed Technology, the technology division of a full-service CRO with its encapsia clinical data suite, announced today a new interoperability in their clinical trial software systems.
Partnership secures access to reserved cGMP capacity and resources at Yposkesi for manufacturing to support the global development and commercialization of Axovant’s gene therapy programs
MagForce AG, a leading medical device company in the field of nanomedicine focused on oncology, published today its financial results as of and for the year ended December 31, 2018 as well as operative highlights.
Polyphor AG announced that it will provide an overview on its Outer Membrane Protein Targeting Antibiotics programs at the American Society of Microbiology Microbe 2019 Conference taking place in San Francisco, California, from June 20 to 24, 2019.
Promore Pharma AB, a Swedish biopharmaceutical developer of therapeutic peptides, announced that half of the patients have been enrolled and started the treatment in the company’s Phase II-study with the company’s product candidate LL-37 for treatment of venous leg ulcers.
Biotech and pharma companies strengthen their leadership teams and committees with new appointments.
The public’s perception of the drug industry can be confusing. Recent studies take a hard look at the industry from different perspectives.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
The sealant was developed by Grifols and combines two plasma proteins, fibrinogen and thrombin. The spray is administered with New Jersey-based Ethicon’s airless spray device.
According to a report, GSK has bundled the products into three separate packets in order to attract regional buyers.
PRESS RELEASES